Total Payments
$101,259
2024 Payments
$1,039
Companies
7
Transactions
52
Medicare Patients
295
Medicare Billing
$48,766
Payment Breakdown by Category
Research$86,745 (85.7%)
Consulting$10,290 (10.2%)
Food & Beverage$2,155 (2.1%)
Travel$2,050 (2.0%)
Other$19.42 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $86,745 | 14 | 85.7% |
| Consulting Fee | $10,290 | 5 | 10.2% |
| Food and Beverage | $2,155 | 26 | 2.1% |
| Travel and Lodging | $2,050 | 6 | 2.0% |
| Grant | $19.42 | 1 | 0.0% |
Payments by Type
Research
$86,745
14 transactions
General
$14,514
38 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| NEUROPACE, INC. | $97,067 | 37 | $0 (2024) |
| Jazz Pharmaceuticals Inc. | $3,691 | 4 | $0 (2023) |
| UCB, Inc. | $303.27 | 6 | $0 (2024) |
| SK Life Science, Inc. | $135.36 | 1 | $0 (2024) |
| LivaNova USA, Inc. | $25.01 | 2 | $0 (2018) |
| Medtronic, Inc. | $19.42 | 1 | $0 (2022) |
| Medtronic USA, Inc. | $17.18 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,039 | 3 | NEUROPACE, INC. ($850.00) |
| 2023 | $5,001 | 8 | Jazz Pharmaceuticals Inc. ($3,691) |
| 2022 | $180.68 | 3 | UCB, Inc. ($161.26) |
| 2021 | $126.17 | 1 | NEUROPACE, INC. ($126.17) |
| 2020 | $17.18 | 1 | Medtronic USA, Inc. ($17.18) |
| 2019 | $124.17 | 2 | NeuroPace, Inc. ($124.17) |
| 2018 | $4,131 | 10 | NEUROPACE, INC. ($4,074) |
| 2017 | $90,640 | 24 | NEUROPACE, INC. ($90,640) |
All Payment Transactions
52 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | SK Life Science, Inc. | XCOPRI (Drug) | Food and Beverage | In-kind items and services | $135.36 | General |
| Category: Neurology | ||||||
| 07/09/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $53.51 | General |
| Category: Neurology | ||||||
| 05/24/2024 | NEUROPACE, INC. | RNS Neurostimulator Kit (Device) | Consulting Fee | Cash or cash equivalent | $850.00 | General |
| Category: Epilepsy | ||||||
| 12/11/2023 | Jazz Pharmaceuticals Inc. | EPIDIOLEX (Drug) | Consulting Fee | Cash or cash equivalent | $3,540.00 | General |
| Category: NEUROLOGY | ||||||
| 12/07/2023 | Jazz Pharmaceuticals Inc. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $20.29 | General |
| Category: NEUROLOGY | ||||||
| 12/01/2023 | NEUROPACE, INC. | RNS Neurostimulator Kit (Device) | Food and Beverage | In-kind items and services | $153.20 | General |
| Category: Epilepsy | ||||||
| 12/01/2023 | Jazz Pharmaceuticals Inc. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $83.86 | General |
| Category: NEUROLOGY | ||||||
| 12/01/2023 | Jazz Pharmaceuticals Inc. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $47.34 | General |
| Category: NEUROLOGY | ||||||
| 11/14/2023 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $22.67 | General |
| Category: Neurology | ||||||
| 07/05/2023 | NEUROPACE, INC. | RNS Neurostimulator Kit (Device) | Consulting Fee | Cash or cash equivalent | $1,100.00 | General |
| Category: Epilepsy | ||||||
| 05/12/2023 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $33.50 | General |
| Category: Neurology | ||||||
| 12/04/2022 | UCB, Inc. | — | Food and Beverage | In-kind items and services | $119.87 | General |
| 05/06/2022 | Medtronic, Inc. | VISUALASE (Device) | Grant | Cash or cash equivalent | $19.42 | General |
| Category: MRI-guided laser ablation | ||||||
| 04/07/2022 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $41.39 | General |
| Category: Neurology | ||||||
| 12/03/2021 | NEUROPACE, INC. | RNS System (Device) | Food and Beverage | In-kind items and services | $126.17 | General |
| Category: Epilepsy | ||||||
| 07/20/2020 | Medtronic USA, Inc. | ACTIVA (Device) | Food and Beverage | In-kind items and services | $17.18 | General |
| Category: Deep Brain Neurostimulation | ||||||
| 12/06/2019 | NeuroPace, Inc. | RNS System (Device) | Food and Beverage | In-kind items and services | $111.33 | General |
| Category: Epilepsy | ||||||
| 08/19/2019 | NeuroPace, Inc. | RNS System (Device) | Food and Beverage | In-kind items and services | $12.84 | General |
| Category: Epilepsy | ||||||
| 12/02/2018 | NEUROPACE, INC. | RNS System (Device) | Food and Beverage | Cash or cash equivalent | $121.24 | General |
| Category: Epilepsy | ||||||
| 11/07/2018 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $32.33 | General |
| Category: Neurology | ||||||
| 11/06/2018 | LivaNova USA, Inc. | VNS Therapy (Device) | Food and Beverage | In-kind items and services | $11.50 | General |
| Category: VNS Therapy (Product Class) | ||||||
| 07/24/2018 | LivaNova USA, Inc. | VNS Therapy (Device) | Food and Beverage | In-kind items and services | $13.51 | General |
| Category: VNS Therapy (Product Class) | ||||||
| 04/30/2018 | NEUROPACE, INC. | RNS System (Device) | Consulting Fee | Cash or cash equivalent | $2,800.00 | General |
| Category: Epilepsy | ||||||
| 04/30/2018 | NEUROPACE, INC. | RNS System (Device) | Travel and Lodging | Cash or cash equivalent | $46.33 | General |
| Category: Epilepsy | ||||||
| 04/29/2018 | NEUROPACE, INC. | RNS System (Device) | Travel and Lodging | Cash or cash equivalent | $463.46 | General |
| Category: Epilepsy | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| RNS System Long-term Treatment Clinical Investigation | NEUROPACE, INC. | $86,745 | 14 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 70 | 101 | $39,620 | $12,102 |
| 2022 | 3 | 57 | 95 | $36,098 | $11,607 |
| 2021 | 5 | 106 | 138 | $47,944 | $14,010 |
| 2020 | 3 | 62 | 99 | $34,450 | $11,048 |
Total Patients
295
Total Services
433
Medicare Billing
$48,766
Procedure Codes
15
All Medicare Procedures & Services
15 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 95720 | Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | Facility | 2023 | 26 | 52 | $27,144 | $8,678 | 32.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 15 | 20 | $8,376 | $2,085 | 24.9% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2023 | 29 | 29 | $4,100 | $1,339 | 32.7% |
| 95720 | Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | Facility | 2022 | 20 | 55 | $28,683 | $9,316 | 32.5% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2022 | 25 | 25 | $3,550 | $1,177 | 33.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 12 | 15 | $3,865 | $1,113 | 28.8% |
| 95720 | Continuous measurement of brain wave activity with video (veeg), 12-26 hours, with health care professional analysis, interpretation and report | Facility | 2021 | 32 | 57 | $29,235 | $8,635 | 29.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 11 | 16 | $5,872 | $1,891 | 32.2% |
| 95816 | Measurement and recording of brain wave (eeg) activity, awake and drowsy | Facility | 2021 | 25 | 26 | $3,650 | $1,068 | 29.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 13 | 13 | $3,250 | $1,068 | 32.9% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 14 | 15 | $4,380 | $969.50 | 22.1% |
| 95819 | Measurement and recording of brain wave (eeg) activity, awake and asleep | Facility | 2021 | 11 | 11 | $1,557 | $378.04 | 24.3% |
| 95720 | Continuous measurement of brain wave activity with video (veeg), 12-26 hours, with health care professional analysis, interpretation and report | Facility | 2020 | 25 | 50 | $25,500 | $8,674 | 34.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 22 | 33 | $6,705 | $1,642 | 24.5% |
| 95816 | Measurement and recording of brain wave (eeg) activity, awake and drowsy | Facility | 2020 | 15 | 16 | $2,245 | $732.84 | 32.6% |
About Dr. David Spencer, MD
Dr. David Spencer, MD is a Neurology healthcare provider based in Portland, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1962419895.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Spencer, MD has received a total of $101,259 in payments from pharmaceutical and medical device companies, with $1,039 received in 2024. These payments were reported across 52 transactions from 7 companies. The most common payment nature is "" ($86,745).
As a Medicare-enrolled provider, Spencer has provided services to 295 Medicare beneficiaries, totaling 433 services with total Medicare billing of $48,766. Data is available for 4 years (2020–2023), covering 15 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Portland, OR
- Active Since 08/02/2006
- Last Updated 07/13/2007
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1962419895
Products in Payments
- RNS System (Device) $94,964
- EPIDIOLEX (Drug) $3,691
- RNS Neurostimulator Kit (Device) $2,103
- XCOPRI (Drug) $135.36
- Briviact (Drug) $107.22
- Fintepla (Drug) $76.18
- VNS Therapy (Device) $25.01
- VISUALASE (Device) $19.42
- ACTIVA (Device) $17.18
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Portland
Kyle Smoot, M.d, M.D
Neurology — Payments: $944,765
Neurology $944,765
Stanley Cohan, M.d, M.D
Neurology — Payments: $664,935
Neurology $664,935
Dr. Chafic Karam, M.d, M.D
Neurology — Payments: $647,064
Neurology $647,064
Dr. John Dolan, D.o, D.O
Neurology — Payments: $550,588
Neurology $550,588
Kiren Kresa-Reahl, M.d, M.D
Neurology — Payments: $421,575
Neurology $421,575
Matthew Brodsky, Md, MD
Neurology — Payments: $244,252
Neurology $244,252